💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

Spurned bidder returns for Australia's Healthscope with shareholder backing

Published 2018-10-22, 10:48 p/m
Spurned bidder returns for Australia's Healthscope with shareholder backing
AXJO
-
BN
-
HSO
-

* BGH-led consortium returns with A$4.1 bid for Healthscope

* Bid price same as offer rejected in May

* Healthscope shares hit 7-week high

By Tom Westbrook

SYDNEY Oct 23 (Reuters) - Australian private equity firm BGH Capital and its partners lobbed a second A$4.1 billion ($2.9 billion) bid for hospital operator Healthscope Ltd HSO.AX on Tuesday, this time with a top shareholder's support.

Healthscope is a hot takeover target, lately posting falling profits, but seen by investors and its suitors as a long-term bet on Australia's ageing population.

It rejected as too cheap an identically priced earlier offer from BGH and its consortium partners, as well as a higher one from Canadian investment firm Brookfield Asset Management BAMa.TO in May, refusing due diligence. on Tuesday Healthscope said it had received assurances from BGH that the repeated offer had the backing of No.2 shareholder Ellerston Capital, giving it the support of almost a quarter of its register.

Healthscope shares soared 20 percent to a 7-week high following the announcement.

"It looks like a reasonable price," said Morningstar analyst Gareth James, adding Ellerston's backing for granting due diligence, plus a languishing share price heaped pressure on Healthscope to open its books to the bidders.

"I think it's unlikely that they would have come back for a second bid without believing that they're in a stronger position than they were."

The offer at A$2.36 per share is lower than Brookfield's rejected bid of A$2.50 but 32 percent higher than Healthscope's closing price on Monday. The share price jumped to A$2.17 on Tuesday, in a falling broader market .AXJO , their highest since September.

Healthscope said it was assessing the proposal and added it had not heard directly from Ellerston about its support. BGH declined to comment.

Ellerston, which owns 9.4 percent of Healthscope, also declined to comment, as did pension fund AustralianSuper, part of the bidding consortium and Healthscope's largest shareholder with a 14 percent stake.

The group behind the takeover approach also includes the Canada Pension Plan Investment Board, the Ontario Teachers' Pension Plan Board and Singaporean sovereign wealth fund GIC.

Australia's second-largest private hospital operator became a takeover target as shrinking patient demand and cuts to private health insurance payouts weigh on its profits and shares.

Investors and analysts see the problems as temporary, as demographic shifts underpin demand for elective surgery and hospital stays in the long run.

But in the four years since it was floated, Healthscope has issued at least two profit warnings as Australians increasingly opt for public health services.

It reported in August that its annual operating profit had halved and outlined plans to spin off, sell and lease back some of its hospital real estate. ($1 = 1.4126 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.